1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470 "Cancer")
Fax: (011) 852-2855-3464
1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
Original Article
You have full text access to this OnlineOpen article
Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance
Article first published online: 18 JAN 2002
DOI: 10.1002/cncr.10211
Copyright © 2002 American Cancer Society
Additional Information
How to Cite
Chang, H. W., Chow, V., Lam, K. Y., Wei, W. I. and Wing Yuen, A. P. (2002), Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance. Cancer, 94: 386–392. doi: 10.1002/cncr.10211
Publication History
- Issue published online: 18 JAN 2002
- Article first published online: 18 JAN 2002
- Manuscript Accepted: 24 SEP 2001
- Manuscript Revised: 29 AUG 2001
- Manuscript Received: 21 MAY 2001
Funded by
- Kadoorie Cancer Research Fund
- The University of Hong Kong
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , , , Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma, Journal of Surgical Oncology, 2012, 105, 8Direct Link:
- 2, , , , , Epigenetic Dysregulation in Laryngeal Squamous Cell Carcinoma, Journal of Oncology, 2012, 2012, 1
- 3, , Methylation-Mediated Molecular Dysregulation in Clinical Oral Malignancy, Journal of Oncology, 2012, 2012, 1
- 4, , , , , Screening of drugs to counteract human papillomavirus 16 E6 repression of E-cadherin expression, Investigational New Drugs, 2012,
- 5, , , An overview of the molecular pathology of head and neck cancer, and its clinical implications, Periodontology 2000, 2011, 57, 1Direct Link:
- 6, , , DNA hypermethylation as an epigenetic mark for oral cancer diagnosis, Journal of Oral Pathology & Medicine, 2011, 40, 9Direct Link:
- 7, , , , DNA methylation in oral squamous cell carcinoma: molecular mechanisms and clinical implications, Oral Diseases, 2011, 17, 8Direct Link:
- 8
- 9, , , , , , Altered Expression of E-cadherin by Hepatocyte Growth Factor and Effect on the Prognosis of Nasopharyngeal Carcinoma, Annals of Surgical Oncology, 2010, 17, 7, 1927
- 10, , , , , DNA methylation or histone modification status in metastasis and angiogenesis-related genes: a new hypothesis on usage of DNMT inhibitors and S-adenosylmethionine for genome stability, Cancer and Metastasis Reviews, 2010, 29, 4, 655
- 11, , , Prognostic evaluation of oral tongue cancer: Means, markers and perspectives (II), Oral Oncology, 2010, 46, 9, 636
- 12, , , , , , Promoter hypermethylation and expression profile of MGMT and CDH1 genes in oral cavity cancer, Archives of Oral Biology, 2010, 55, 10, 809
- 13, Epigenetics in Head and Neck Cancer, Korean Journal of Otorhinolaryngology-Head and Neck Surgery, 2009, 52, 12, 943
- 14, , , , , Gene hypermethylation in tumor tissue of advanced oral squamous cell carcinoma patients, Oral Oncology, 2009, 45, 12, 1051
- 15, , , , , , , The expression of E-cadherin at the invasive tumor front of oral squamous cell carcinoma: immunohistochemical and RT-PCR analysis with clinicopathological correlation, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2009, 107, 4, 547
- 16, , , , , , Upregulation of vimentin and aberrant expression of E-cadherin/β-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome, Modern Pathology, 2009, 23, 2, 213
- You have free access to this content17, , , , , , , , E-cadherin abnormalities resulting from CPG methylation promoter in metastatic and nonmetastatic oral cancer, Head & Neck, 2008, 30, 1Direct Link:
- 18, , , , , , , , , , E-cadherin loss and ΔNp73L expression in oral squamous cell carcinomas showing aggressive behavior, Head & Neck, 2008, 30, 11Direct Link:
- 19, , , , , , , , , , , Epithelial to mesenchymal transition in head and neck squamous carcinoma, Cancer, 2008, 112, 9Direct Link:
- 20, , , , Hypermethylation of E-cadherin is an independent predictor of improved survival in head and neck squamous cell carcinoma, Cancer, 2008, 113, 7Direct Link:
- 21, A Correlation Between the Reduced Expression of E-Cadherin and Promoter Hypermethylation in Oral Squamous Cell Carcinoma, Journal of Oral and Maxillofacial Surgery, 2007, 65, 9, 34.e1
- 22, , , , , , , , Fascin over-expression is associated with aggressiveness of oral squamous cell carcinoma, Cancer Letters, 2007, 254, 2, 308
- 23, , , , , , , , In breast carcinoma dysadherin expression is correlated with invasiveness but not with E-cadherin, British Journal of Cancer, 2007,
- 24, , , Induction of uPA gene expression by the blockage of E-cadherin via Src- and Shc-dependent Erk signaling, FEBS Journal, 2007, 274, 1Direct Link:
- 25, , , , Loss of epithelium cadherin expression is associated with reduced overall survival and disease-free survival in early-stage squamous cell cervical carcinoma, International Journal of Gynecological Cancer, 2007, 17, 4Direct Link:
- 26, , , , , , , , , , , Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM23 in head and neck cancer, Cancer Genetics and Cytogenetics, 2007, 173, 1, 31
- 27, , , , , , , , , , Aberrant expression of β- and γ-catenin is an independent prognostic marker in oral squamous cell carcinoma, International Journal of Oral and Maxillofacial Surgery, 2006, 35, 4, 356
- 28, , , , , , , Dysadherin Expression in Head and Neck Squamous Cell Carcinoma, The American Journal of Surgical Pathology, 2006, 30, 2, 185
- 29, , Epigenetic diagnostics of cancer — the application of DNA methylation markers, Journal of Applied Genetics, 2006, 47, 4, 365
- 30, , , , , , , , Expression patterns of dysadherin and E-cadherin in lymph node metastases of colorectal carcinoma, Virchows Archiv, 2006, 448, 6, 763
- 31, , , , Oral squamous cell carcinoma: Review of prognostic and predictive factors, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2006, 102, 1, 67
- 32, , Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma, The Lancet Oncology, 2006, 7, 1, 77
- 33, , , , , , , , Promoter methylation of P16, RARβ, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing, British Journal of Cancer, 2006, 94, 4, 561
- 34, , , , , Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma, Oral Oncology, 2006, 42, 2, 190
- 35, The epigenetics of oral cancer, International Journal of Oral and Maxillofacial Surgery, 2006, 35, 2, 101
- 36, , , , , , , Characterization of human PA2.26 antigen (T1α–2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas, International Journal of Cancer, 2005, 113, 6Direct Link:
- 37, , , , E-cadherin is a selective and strongly dominant prognostic factor in squamous cell carcinoma: A comparison of E-cadherin with desmosomal components, International Journal of Cancer, 2005, 114, 5Direct Link:
- 38, , , , , , , , Involvement of dysadherin and E-cadherin in the development of testicular tumours, British Journal of Cancer, 2005, 93, 12, 1382
- 39
- 40, , , , , Progression of head and neck squamous cell cancer, Cancer and Metastasis Reviews, 2005, 24, 1, 107
- 41, , , , , , Regulatory mechanisms controlling human E-cadherin gene expression, Oncogene, 2005, 24, 56, 8277
- 42, , , , , , , APC, β-catenin, and E-cadherin and the development of recurrent endometrial carcinoma, International Journal of Gynecological Cancer, 2004, 14, 5Direct Link:
- 43, , , , , E-cadherin and catenins in early squamous cervical carcinoma, Gynecologic Oncology, 2004, 94, 2, 521
- 44, , , , , , , , Infiltrating leukocytes confound the detection of E-cadherin promoter methylation in tumors, Biochemical and Biophysical Research Communications, 2004, 319, 2, 697
- 45, , , , , , , , , Loss of heterozygosity at 9q33 and hypermethylation of the DBCCR1 gene in oral squamous cell carcinoma, British Journal of Cancer, 2004,
- 46, , , , , , Prognostic Significance of Dysadherin Expression in Tongue Cancer: Immunohistochemical Analysis of 91 Cases, Applied Immunohistochemistry & Molecular Morphology, 2004, 12, 4, 323
- 47, , , , Promoter methylation regulates cadherin switching in squamous cell carcinoma, Biochemical and Biophysical Research Communications, 2004, 315, 4, 850
- 48, , CADHERINS ASMODULATORS OFCELLULARPHENOTYPE, Annual Review of Cell and Developmental Biology, 2003, 19, 1, 207
- 49, , , , , , Correlation of P-cadherin and β-catenin expression and phosphorylation with carcinogenesis in rat tongue cancer induced with 4-nitroquinoline 1-oxide, Oral Oncology, 2003, 39, 5, 506
- 50
- 51, , , , Hypermethylation in promoter region of E-cadherin gene is associated with tumor dedifferention and myometrial invasion in endometrial carcinoma, Cancer, 2003, 97, 4Direct Link:
- 52, , , , , , , Immunohistochemical Expression of Angiogenesis-Related Markers in Oral Squamous Cell Carcinomas With Multiple Metastatic Lymph Nodes, American Journal of Clinical Pathology, 2003, 119, 4, 574
- 53, , , , , , , Immunohistochemical Expression of Angiogenesis-Related Markers in Oral Squamous Cell Carcinomas With Multiple Metastatic Lymph Nodes, American Journal of Clinical Pathology, 2003, 119, 4, 574
- 54Methylation status and expression of E-cadherin and cadherin-11 in gestational trophoblastic diseases, International Journal of Gynecological Cancer, 2003, 13, 6Direct Link: